This review discusses the benefits of combination therapy with the angiotensin type II receptor blocker olmesartan medoxomil (OM) paired with the thiazide diuretic hydrochlorothiazide (HCTZ)
5mg : World Wide Remedies: View Price Most combinations contain an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker with a diuretic
For the properties of the components please consider
In a placebo-controlled, factorial clinical trial of olmesartan medoxomil (2
[2] Initial dose: Amlodipine should start at 2
For instance, if the person with high blood pressure also retains fluid, a diuretic may be added
5-30%) were achieved with combination therapy than with either of monotherapies
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of olmesartan and hydrochlorothiazide combination in the elderly
This 40-week open-label extension of the 12-week double-blind Triple Therapy With Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide in Hypertensive Patients Study (TRINITY) evaluated the efficacy and safety of triple-combination treatments with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide
Olmesartan medoxomil, a prodrug, is hydrolyzed to olmesartan during absorption from the gastrointestinal tract